Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02519309 · ClinicalTrials.gov registry record · NA
Dietary Intervention in Type-2 Diabetes and Pre-Diabetes
A NA study, sponsored by Virta Health.
- Completed
- Registry status
- NA
- Development phase
- 465
- Enrollment target
NCT02519309: Completed NA study, sponsored by Virta Health.
NCT02519309 is a NA study that has completed, run by Virta Health. The registered enrollment target is 465 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02519309, a NA study, has completed, sponsored by Virta Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 465 participants
- Enrollment target
Study Summary
The primary purpose of this research is to demonstrate the therapeutic effects of implementing a well-formulated low carbohydrate lifestyle program over 2 years in patients with type 2 diabetes, pre-diabetes, and metabolic syndrome.
Primary Outcome
Type-2 diabetes status will be evaluated by measuring Hemoglobin A1c (HbA1c)
Interventions
- OTHER Virta Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 465 participants |
| Start Date | 2015-08 |
| Est. Completion | 2021-04 |
| Phase | NA |
What the finished NCT02519309 record still lists
NCT02519309 is an interventional study that assigns participants to a tested intervention. The registered 465 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 1 intervention - of which Virta Program is the first listed.
NCT02519309 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02519309 about?
NCT02519309 is a clinical study titled "Dietary Intervention in Type-2 Diabetes and Pre-Diabetes". The primary purpose of this research is to demonstrate the therapeutic effects of implementing a well-formulated low carbohydrate lifestyle program over 2 years in patients with type 2 diabetes, pre-diabetes, and metabolic syndrome.
What is the current status of trial NCT02519309?
This trial is currently completed. It is a NA study. The enrollment target is 465 participants. The study started on 2015-08. Estimated completion is 2021-04.
What interventions are being tested in trial NCT02519309?
The interventions under investigation include: Virta Program (OTHER).
Who is sponsoring clinical trial NCT02519309?
This trial is sponsored by Virta Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02519309's enrollment target sits among peer trials
465 222nd of 2000 higher than 1,779 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06717698 · 465 participants · Phase 2
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- NCT07420283 · 465 participants · Phase 2
A Study of Brenipatide in Participants With Opioid Use Disorder
- NCT05312879 · 466 participants · Phase 2
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease
- NCT06917404 · 466 participants · Phase 3
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia